Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Metabolic Associated Fatty Liver Disease in Patients With Type 2 Diabetes in Jiangsu Province of China: a Prospective, Multicenter, Real-world Study

NCT05597709 is registered in ClinicalTrials.gov with Wuxi Hisky Medical Technology Co Ltd as lead sponsor.

NCT NCT05597709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05597709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Metabolic Associated Fatty Liver Disease in Patients With Type 2 Diabetes in Jiangsu Province of China: a Prospective, Multicenter, Real-world Study
Lead sponsor
Wuxi Hisky Medical Technology Co Ltd
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2022
Completion date
June 1, 2027
Enrollment
2,900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic associated fatty liver disease, type 2 diabetes mellitus in remission